PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Mittlmeier LM, Unterrainer M, Todica A, Cyran CC, Rodler S, Bartenstein P, Stief CG, Ilhan H, Staehler M.
Mittlmeier LM, et al. Among authors: todica a.
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2216-2217. doi: 10.1007/s00259-019-04636-6. Epub 2020 Jan 11.
Eur J Nucl Med Mol Imaging. 2020.
PMID: 31925458
No abstract available.